Found: 1
Select item for more details and to access through your institution.
Targeting of the WT1 fragment to human dendritic cells improves leukemia-specific T-cell responses providing an alternative approach to WT1-based vaccination.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 3, p. 319, doi. 10.1007/s00262-016-1938-y
- By:
- Publication type:
- Article